Bulletin
Investor Alert

New York Markets Close in:

Dicerna Pharmaceuticals Inc.

NAS: DRNA

GO
/marketstate/country/us

Market open

 --Real time quotes

Sep 25, 2020, 10:20 a.m.

/zigman2/quotes/203776010/composite

$

18.73

Change

+0.44 +2.38%

Volume

Volume 28,360

Real time quotes

/zigman2/quotes/203776010/composite

Previous close

$ 18.29

$ 18.73

Change

+0.44 +2.38%

Day low

Day high

$18.16

$18.73

Open

52 week low

52 week high

$11.75

$27.68

Open

Insider Actions for Dicerna Pharmaceuticals Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
09/16/2020 Bob D. Brown
See Remarks
21,250   Derivative/Non-derivative trans. at $3.42 per share. 72,675
09/14/2020 Bob D. Brown
See Remarks
267   Derivative/Non-derivative trans. at $3.42 per share. 913
09/01/2020 Douglas M. Fambrough
President and CEO; Director
10,000   Acquisition at $18.06 per share. 180,600
08/03/2020 Bob D. Brown
See Remarks
2,521   Disposition at $22.8 per share. 57,478
08/03/2020 Bob D. Brown
See Remarks
5,664   Disposition at $22.34 per share. 126,533
08/03/2020 James B. Weissman
EVP & Chief Operating Officer
1,432   Disposition at $22.8 per share. 32,649
08/03/2020 James B. Weissman
EVP & Chief Operating Officer
2,928   Disposition at $22.31 per share. 65,323
08/03/2020 Bob D. Brown
See Remarks
8,185   Derivative/Non-derivative trans. at $3.42 per share. 27,992
08/03/2020 James B. Weissman
EVP & Chief Operating Officer
259   Derivative/Non-derivative trans. at $3.42 per share. 885
08/03/2020 James B. Weissman
EVP & Chief Operating Officer
4,101   Derivative/Non-derivative trans. at $2.97 per share. 12,179
07/01/2020 Bob D. Brown
See Remarks
2,371   Disposition at $26.85 per share. 63,661
07/01/2020 Bob D. Brown
See Remarks
5,814   Disposition at $26.36 per share. 153,257
07/01/2020 James B. Weissman
EVP & Chief Operating Officer
1,307   Disposition at $26.87 per share. 35,119
07/01/2020 James B. Weissman
EVP & Chief Operating Officer
3,053   Disposition at $26.39 per share. 80,568
07/01/2020 Bob D. Brown
See Remarks
8,185   Derivative/Non-derivative trans. at $3.42 per share. 27,992
07/01/2020 James B. Weissman
EVP & Chief Operating Officer
4,360   Derivative/Non-derivative trans. at $2.97 per share. 12,949
06/19/2020 Bob D. Brown
See Remarks
9,670   Disposition at $25 per share. 241,750
06/19/2020 Bob D. Brown
See Remarks
9,670   Derivative/Non-derivative trans. at $2.97 per share. 28,719
06/01/2020 Bob D. Brown
See Remarks
8,185   Disposition at $21.01 per share. 171,966
06/01/2020 James B. Weissman
EVP & Chief Operating Officer
4,360   Disposition at $21.06 per share. 91,821
06/01/2020 Bob D. Brown
See Remarks
8,185   Derivative/Non-derivative trans. at $3.42 per share. 27,992
06/01/2020 James B. Weissman
EVP & Chief Operating Officer
4,360   Derivative/Non-derivative trans. at $2.97 per share. 12,949
05/11/2020 Bob D. Brown
See Remarks
13,281   Disposition at $24 per share. 318,744
05/11/2020 Bob D. Brown
See Remarks
13,281   Derivative/Non-derivative trans. at $2.97 per share. 39,444
05/05/2020 Bob D. Brown
See Remarks
8,185   Disposition at $21 per share. 171,885
05/05/2020 Bob D. Brown
See Remarks
8,185   Derivative/Non-derivative trans. at $3.42 per share. 27,992
05/04/2020 James B. Weissman
EVP & Chief Operating Officer
4,360   Disposition at $20.2 per share. 88,072
05/04/2020 James B. Weissman
EVP & Chief Operating Officer
4,360   Derivative/Non-derivative trans. at $2.97 per share. 12,949

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
8 Purchases
8 Sales
56,607
25,090
Last 6 months
20 Purchases
19 Sales
176,567
145,050
Last 12 months
47 Purchases
55 Sales
540,468
6,262,813

Officers and Executives

Dr. Douglas M. Fambrough
President, Chief Executive Officer & Director
Mr. James B. Weissman
Chief Operating Officer & Executive Vice President
Mr. Douglas W. Pagán
Chief Financial Officer
Mr. Shreeram Aradhye
Chief Medical Officer
Dr. Bob D. Brown
Chief Scientific Officer
Mr. Robert D. Ciappenelli
Chief Commercial Officer
Mr. David J. Caponera
Head-Patient Advocacy & Patient Services
Dr. David W. Miller
SVP-Operations & Alliance Management
Dr. Hardean E. Achneck
Vice President & Head-Medical Development
Ms. Regina M. DeTore Paglia
Senior Vice President-Human Resources
Ms. Ling Zeng
Secretary & Chief Legal Officer
Dr. Steven A. Kates
Vice President-Regulatory Affairs
Mr. J. Kevin Buchi
Chairman
Mr. Patrick M. Gray
Independent Director
Dr. Stephen K. Doberstein
Independent Director
Dr. Stephen J. Hoffman
Independent Director
Dr. Martin I. Freed
Independent Director
Ms. Cynthia Smith
Independent Director
Mr. Marc D. Kozin
Independent Director
Ms. Anna Protopapas
Independent Director
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.